← back to search

Pierre Hainaut

Institut Pasteur · FR
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Medicine, Cancer, Li–Fraumeni syndrome, Germline, Biology, and Breast cancer.
h-index
citations
6,188
works
26
NIH funding
primary concept
email

Recent publications

Cancer risk in carriers of <i>TP53</i> germline variants grouped into different functional categories
JNCI Cancer Spectrum 2025cited by 5position: middledoi
Clustering of TP53 variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome
iScience 2024cited by 22position: lastdoi
Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis
Cell Discovery 2024cited by 18position: middledoi
From cultivation to cancer: formation of <i>N</i> -nitrosamines and other carcinogens in smokeless tobacco and their mutagenic implications
Critical Reviews in Toxicology 2023cited by 31position: middledoi
Reply to Li and Colleagues
JNCI Journal of the National Cancer Institute 2023cited by 1position: middledoi
The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute
Cell Death and Differentiation 2022cited by 163position: middledoi
Heterozygous <i>BRCA1</i> and <i>BRCA2</i> and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer
JNCI Journal of the National Cancer Institute 2022cited by 49position: middledoi
Genotype–phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry
Journal of Hematology & Oncology 2022cited by 30position: middledoi
Reply to Evans and Woodward
JNCI Journal of the National Cancer Institute 2022cited by 1position: middledoi
Analysis of the Li-Fraumeni Spectrum Based on an International Germline <i>TP53</i> Variant Data Set
JAMA Oncology 2021cited by 140position: middledoi
A novel whole blood gene expression signature for asthma, dermatitis, and rhinitis multimorbidity in children and adolescents
Allergy 2020cited by 97position: middledoi
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Nature Reviews Gastroenterology & Hepatology 2019cited by 4,342position: middledoi
Deciphering the Impact of Early-Life Exposures to Highly Variable Environmental Factors on Foetal and Child Health: Design of SEPAGES Couple-Child Cohort
International Journal of Environmental Research and Public Health 2019cited by 80position: middledoi
Cost‐effectiveness of early cancer surveillance for patients with Li–Fraumeni syndrome
Pediatric Blood & Cancer 2019cited by 33position: middledoi
Systems medicine disease maps: community-driven comprehensive representation of disease mechanisms
npj Systems Biology and Applications 2018cited by 128position: middledoi
Recommended Guidelines for Validation, Quality Control, and Reporting of <i>TP53</i> Variants in Clinical Practice
Cancer Research 2017cited by 94position: middledoi
Natural variations of copper and sulfur stable isotopes in blood of hepatocellular carcinoma patients
Proceedings of the National Academy of Sciences 2015cited by 148position: lastdoi
Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma
International Journal of Cancer 2014cited by 62position: lastdoi
Anthropometry, Silhouette Trajectory, and Risk of Breast Cancer in Mexican Women
American Journal of Preventive Medicine 2014cited by 48position: middledoi
Breast cancer in pre-menopausal women in West Africa: Analysis of temporal trends and evaluation of risk factors associated with reproductive life
The Breast 2013cited by 51position: lastdoi
Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures
Carcinogenesis 2013cited by 33position: middledoi
Targeting the hallmarks of cancer
Current Opinion in Oncology 2012cited by 245position: firstdoi
Toward a roadmap in global biobanking for health
European Journal of Human Genetics 2012cited by 172position: middledoi
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium
Cancer Genetics 2012cited by 104position: middledoi
Drosophila p53 isoforms differentially regulate apoptosis and apoptosis-induced proliferation
Cell Death and Differentiation 2012cited by 56position: middledoi
Sources of Pre-Analytical Variations in Yield of DNA Extracted from Blood Samples: Analysis of 50,000 DNA Samples in EPIC
PLoS ONE 2012cited by 35position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

David Malkin · University of Toronto8 papers (2012–2024)Christian P. Kratz · Medizinische Hochschule Hannover7 papers (2021–2025)Maria Isabel Achatz · Hospital Sírio-Libanês4 papers (2012–2024)Tim Ripperger · Medizinische Hochschule Hannover4 papers (2022–2025)Anika Großhennig · Medizinische Hochschule Hannover4 papers (2022–2025)Stefan M. Pfister · Université du Québec4 papers (2022–2025)Amelie Plymoth · Karolinska Institutet3 papers (2012–2019)Natalie Jäger · Hopp Children's Cancer Center Heidelberg3 papers (2022–2023)Riccardo Berutti · Technical University of Munich3 papers (2022–2023) · 3 papers (2022–2023)Dmitrii Smirnov · Technical University of Munich3 papers (2022–2023)Amina Amadou · University of Regensburg3 papers (2014–2024)Joshua D. Schiffman · University of Utah3 papers (2012–2021)Robert J. Autry · German Cancer Research Center3 papers (2022–2023)Sebastian M. Waszak · University Hospital Heidelberg3 papers (2022–2023)Holger Prokisch · Technical University of Munich3 papers (2022–2023)Claire Freyçon · McGill University Health Centre2 papers (2021–2024)Judith Penkert · Medizinische Hochschule Hannover2 papers (2024–2025)D. Gareth Evans · Translational Research Institute2 papers (2012–2021) · 2 papers (2024–2025)